Diferenciação miogênica “in vitro” de células tronco mesenquimais murinas de diferentes origens

Muscular dystrophy refers to a group of more than 30 genetical disorders characterized by progressive weakness and degeneration of the skeletal muscle. No effective therapy is available at present. Recent studies have reported that the transplantation of stem cells can offer an important potential therapy for genetic diseases. Adult bone marrow mesenchymal stem cells have been identified as a nonhematopoietic stem cell population capable of self-renewal with the ability to differentiate into many cell lineages, including bone, fat, cartilage and connective tissue. Because of their similarity with muscle progenitor cells, when they are injected in affected individuals, they are able to migrate into areas of skeletal muscle degeneration and participate in the regeneration process. The adipose tissue represents an alternative source of MSCs that, as the MSCs derived from bone marrow, are capable of in vitro differentiation into osteogenic, adipogenic, myogenic and chondrogenic lineages. The objective of this project is to investigate the “in vitro” myogenic potential of mesenchymal stem cells derived from murine bone marrow and adipose tissue. Four experimental groups were analyzed: mice from lineages Lama2dy-2J/J and C57black and, C2C12 lineage cells and transformed C2C12 expressing the eGFP protein. MSCs cultures were obtained by flushing the bone marrow femurs and tibials with α-MEM or by the subcutaneous and inguinal fat from the mice. Their characterization was done by flow cytometry and in vitro differentiation. Muscle differentiation was studied through the analysis of the expression of transcriptional factors involved in muscle differentiation and/or the presence and amount of specific proteins from muscle differentiated cell. The pluripotency from bone marrow MSCs of the two lineages was evidenced and, in the muscular differentiation... (Complete abstract click electronic access below)

Avaliação preliminar dos efeitos de Bidens pilosa L. sobre a obesidade induzida por dieta hipercalórica

The obesity along with overweight has been considered one of the most serious public health problems in the world, especially because they are the main risk factors for many chronic diseases such as coronary heart disease, diabetes mellitus, hypertension and some types of tumors, which are associated with high mortality rates. The use of functional foods and appropriate diets to promote health has grown as a prevention mechanism. Previous studies suggested Bidens pilosa L. for the treatment of disorders associated with obesity, with one important attraction of this regiment is perceived as safer and more effective health than the traditional anorexigen .The aim of this project is to standardize a new model of obesity induced by hipercaloric diet in Swiss mice, and also to evaluate the effect of Bidens pilosa L. extract in the reduction of food intake, weight and toxicity. After induction of obesity, the animals were treated for 21 days with the extract. Then the animals were killed and samples were collected for further analysis. Preliminary, the effect of this product has being evaluated on the daily food intake and body weight. In dose of 100mg/Kg, there were no significant changes in food intake and body weight. Thus, this concentration of Bidens pilosa was not effective in reducing body weight of obese animals, and did not reduce food intake